President Donald Trump is reportedly urging Health and Human Services Secretary Robert F. Kennedy Jr. to implement more aggressive reductions in the number of vaccines recommended for children. This move follows a series of recent actions by the administration aimed at overhauling the nation's immunization policies.
In May 2026, President Trump signed an executive order endorsing a plan to halve the number of vaccines recommended for children. The order directed the Centers for Disease Control and Prevention (CDC) to review a health department assessment that compared U.S. childhood immunization recommendations with those of peer nations. The assessment, co-authored by Dr. Tracy Beth Høeg, concluded that the CDC should update the childhood immunization schedule to align with international consensus, potentially removing vaccines for diseases such as hepatitis A, hepatitis B, meningitis, rotavirus, influenza, and COVID-19 from the recommended schedule.
This directive has sparked significant controversy. Fifteen states with Democratic governors have filed lawsuits against the Department of Health and Human Services (HHS) and Secretary Kennedy, arguing that the proposed changes could lead to increased illness and strain state resources. Health experts have also raised concerns that the reduction in recommended vaccines could erode public trust in the immunization system and lead to higher rates of preventable diseases.
The administration's push to reduce vaccine recommendations is part of a broader effort to reshape public health policies. Secretary Kennedy has previously taken steps such as firing all 17 members of the CDC's Advisory Committee on Immunization Practices (ACIP) and replacing them with his own appointees, many of whom have expressed skepticism about vaccines. These actions have been criticized for potentially undermining the credibility of the CDC and the scientific community.
As the administration continues to advocate for changes to the nation's immunization policies, the debate over vaccine recommendations is likely to intensify. The outcome of ongoing legal challenges and public response will play a crucial role in determining the future of vaccine policy in the United States.